• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫调节作用的耐受益生菌在多发性硬化症。

Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

机构信息

Leishmaniasis Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.

Immunology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Adv Exp Med Biol. 2021;1286:87-105. doi: 10.1007/978-3-030-55035-6_6.

DOI:10.1007/978-3-030-55035-6_6
PMID:33725347
Abstract

Gut microbiota has essential roles in the prevention and progression of multiple sclerosis (MS). The association between the gut microbiota and the central nervous system (CNS) or immune system response of MS patients has been documented in many studies. The composition of the gut microbiota could lead to sensitization or resistance against promotion and development of MS disease. Probiotics are the major part of gut microflorapopulation and could be substituted with tolerogenic probiotics that protect the CNS against autoimmune responses. Tolerogenic probiotics with anti-inflammatory and immuno-modulatory properties have effects on intestinal flora and can reestablish regulatory mucosal and systemic immune responses. Probiotics are able to prevent and restore excessive activation of inflammatory responses, especially autoreactive T cells and inflammatory cytokines. Tolerogenic probiotics, through induction of regulatory T cells and increase of anti-inflammatory cytokines, play a crucial role in controlling inflammation and maintaining tolerance and hemostasis. Therefore, probiotics can be considered as a preventive or therapeutic tool in MS. In the present review, we focus on the immunoregulatory effects of tolerogenic probiotics on the severity of disease, as well as Th1, Th2, and Treg populations in different experimental and human studies of MS.

摘要

肠道微生物群在多发性硬化症(MS)的预防和进展中起着重要作用。许多研究已经记录了肠道微生物群与多发性硬化症患者的中枢神经系统(CNS)或免疫系统反应之间的关联。肠道微生物群的组成可能导致多发性硬化症疾病的促进和发展产生致敏或抵抗。益生菌是肠道微生物群的主要组成部分,可以用具有免疫耐受特性的益生菌来替代,这些益生菌可以保护中枢神经系统免受自身免疫反应的影响。具有抗炎和免疫调节特性的免疫耐受益生菌对肠道菌群有影响,并能重新建立调节性黏膜和系统性免疫反应。益生菌能够预防和恢复炎症反应的过度激活,特别是自身反应性 T 细胞和炎症细胞因子。免疫耐受益生菌通过诱导调节性 T 细胞和增加抗炎细胞因子,在控制炎症和维持耐受和止血方面发挥着关键作用。因此,益生菌可以被认为是多发性硬化症的一种预防或治疗工具。在本综述中,我们重点关注免疫耐受益生菌对多发性硬化症严重程度以及不同实验和人类研究中 Th1、Th2 和 Treg 群体的免疫调节作用。

相似文献

1
Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.免疫调节作用的耐受益生菌在多发性硬化症。
Adv Exp Med Biol. 2021;1286:87-105. doi: 10.1007/978-3-030-55035-6_6.
2
A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis.商业益生菌可诱导实验性自身免疫性脑脊髓炎的耐受性并减少其致病性反应。
Cells. 2020 Apr 7;9(4):906. doi: 10.3390/cells9040906.
3
Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus.耐受性益生菌:系统性红斑狼疮中的潜在免疫调节剂
J Cell Physiol. 2017 Aug;232(8):1994-2007. doi: 10.1002/jcp.25748. Epub 2017 Mar 1.
4
Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.动物双歧杆菌联合植物乳杆菌(来源于人)通过改变 CD4+T 细胞亚群平衡改善多发性硬化症实验模型中的神经炎症。
Biomed Pharmacother. 2017 Nov;95:1535-1548. doi: 10.1016/j.biopha.2017.08.117. Epub 2017 Sep 22.
5
Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.肠道微生物群的操纵影响进展性多发性硬化模型中的免疫反应、轴突保存和运动障碍。
Front Immunol. 2019 Jun 14;10:1374. doi: 10.3389/fimmu.2019.01374. eCollection 2019.
6
The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.肠道-脑轴的重要性以及使用益生菌作为多发性硬化症的一种治疗策略。
Mult Scler Relat Disord. 2023 Mar;71:104547. doi: 10.1016/j.msard.2023.104547. Epub 2023 Feb 2.
7
Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives.肠道微生物组与多发性硬化症:背景、证据和展望。
Nutrients. 2023 Feb 14;15(4):942. doi: 10.3390/nu15040942.
8
The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis.益生菌对免疫应答的影响及其治疗应用:多发性硬化症的一种新治疗选择。
Biomed Pharmacother. 2023 Mar;159:114195. doi: 10.1016/j.biopha.2022.114195. Epub 2023 Jan 10.
9
Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease.源自人类肠道的共生细菌可抑制中枢神经系统炎症和脱髓鞘疾病。
Cell Rep. 2017 Aug 8;20(6):1269-1277. doi: 10.1016/j.celrep.2017.07.031.
10
Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?肠道微生物群和益生菌:重症肌无力的新型免疫系统调节剂?
Ann N Y Acad Sci. 2018 Feb;1413(1):49-58. doi: 10.1111/nyas.13567. Epub 2018 Jan 17.

引用本文的文献

1
The M2 Macrophages Importance Role in Psoriasis.M2巨噬细胞在银屑病中的重要作用
Immun Inflamm Dis. 2025 Jun;13(6):e70211. doi: 10.1002/iid3.70211.
2
Expression of microRNAs in the detection and therapeutic roles of viral infections: Mechanisms and applications.微小RNA在病毒感染检测及治疗作用中的表达:机制与应用
J Virus Erad. 2025 Mar 12;11(1):100586. doi: 10.1016/j.jve.2025.100586. eCollection 2025 Mar.
3
The microbiota-gut-brain axis in myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review of an emerging field.

本文引用的文献

1
Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model.鼠李糖乳杆菌和德氏乳杆菌对苍耳烷诱导狼疮模型调节性 T 细胞的改善作用。
J Cell Physiol. 2019 Jun;234(6):9778-9786. doi: 10.1002/jcp.27663. Epub 2018 Oct 28.
2
Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.免疫耐受与功能:肠道细菌、益生菌、益生元和噬菌体之间的关联。
Front Immunol. 2018 Oct 9;9:2240. doi: 10.3389/fimmu.2018.02240. eCollection 2018.
3
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.
肌痛性脑脊髓炎/慢性疲劳综合征中的微生物群-肠-脑轴:对一个新兴领域的叙述性综述
Eur J Transl Myol. 2025 Mar 31;35(1). doi: 10.4081/ejtm.2025.13690. Epub 2025 Feb 12.
4
Revolutionizing Cancer Treatment: Unveiling the Power of CAR T-cell Therapy.变革癌症治疗:揭示CAR-T细胞疗法的力量。
Curr Pharm Des. 2025;31(13):1020-1036. doi: 10.2174/0113816128336391241107112957.
5
The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances.肠道微生物组:在神经退行性疾病及其治疗进展中的重要作用。
Mol Cell Biochem. 2024 Sep;479(9):2217-2243. doi: 10.1007/s11010-023-04853-6. Epub 2023 Oct 3.
6
The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders.肠道微生物组在多发性硬化症及相关疾病发病机制中的作用。
Cells. 2023 Jun 30;12(13):1760. doi: 10.3390/cells12131760.
7
Regulatory NK cells in autoimmune disease.自身免疫性疾病中的调节性自然杀伤细胞。
Iran J Basic Med Sci. 2023;26(6):609-616. doi: 10.22038/IJBMS.2023.68653.14969.
8
The role of HLA genotypes in understanding the pathogenesis of severe COVID-19.HLA基因型在理解重症COVID-19发病机制中的作用。
Egypt J Med Hum Genet. 2023;24(1):14. doi: 10.1186/s43042-023-00392-3. Epub 2023 Jan 26.
9
Clinical Application Value of PS128 in Patients with Anxiety Disorders.PS128在焦虑症患者中的临床应用价值
Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):560-566. doi: 10.9758/cpn.2022.20.3.560.
10
SARS-CoV-2 triggering autoimmune diseases.SARS-CoV-2 引发自身免疫性疾病。
Cytokine. 2022 Jun;154:155873. doi: 10.1016/j.cyto.2022.155873. Epub 2022 Apr 5.
关注肠-脑轴:多发性硬化、肠道屏障和微生物组。
World J Gastroenterol. 2018 Oct 7;24(37):4217-4223. doi: 10.3748/wjg.v24.i37.4217.
4
The immunomodulatory role of probiotics in allergy therapy.益生菌在过敏治疗中的免疫调节作用。
J Cell Physiol. 2019 Mar;234(3):2386-2398. doi: 10.1002/jcp.27263. Epub 2018 Sep 7.
5
In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.体内研究:经诱导产生系统性红斑狼疮的老鼠用耐受性乳酸菌益生菌治疗后 Th1-Th17 减少。
J Cell Physiol. 2018 Jan;234(1):642-649. doi: 10.1002/jcp.26819. Epub 2018 Aug 4.
6
Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics.使用鼠李糖乳杆菌和德氏乳杆菌作为免疫原性益生菌来生成耐受原性树突状细胞。
J Cell Biochem. 2018 Sep;119(9):7865-7872. doi: 10.1002/jcb.27203. Epub 2018 Jun 26.
7
Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up.多模态干预对多发性硬化症患者健康结局和遵医行为的影响:3 年随访。
PLoS One. 2018 May 23;13(5):e0197759. doi: 10.1371/journal.pone.0197759. eCollection 2018.
8
Microglial control of astrocytes in response to microbial metabolites.小胶质细胞对微生物代谢物的星形胶质细胞的控制作用。
Nature. 2018 May;557(7707):724-728. doi: 10.1038/s41586-018-0119-x. Epub 2018 May 16.
9
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.多发性硬化症患者使用维生素和膳食补充剂:综述。
JAMA Neurol. 2018 Aug 1;75(8):1013-1021. doi: 10.1001/jamaneurol.2018.0611.
10
A probiotic modulates the microbiome and immunity in multiple sclerosis.益生菌可调节多发性硬化症的微生物组和免疫系统。
Ann Neurol. 2018 Jun;83(6):1147-1161. doi: 10.1002/ana.25244. Epub 2018 Jun 8.